In conclusion, the results of this study demonstrated that TCS inhibited HCC cells by activating caspase, recruiting CD8+ T cells, enhancing the expression of chemokines and up-regulating M6PR genes to transport GrzB (Figure 9). This evidence concerns the gene CD8A and hepatocellular carcinoma.